India's exports to the UK in select categories surged 24% to $4.98 billion in 2025-26, helping companies offset slowing demand from the United States. The India-UK Comprehensive Economic and Trade Agreement (CETA) launching July 15 is expected to further ease tariffs, opening new growth channels for Indian manufacturing, agriculture, and pharmaceutical firms.
Indian exporters are increasingly shifting their focus toward the United Kingdom as a primary destination to counter the recent slowdown in demand from the United States. Official data for the 2025-26 period shows that while total exports to the UK faced a 7.6% contraction to $13.44 billion, specific product categories bucked this trend with a 24% growth, reaching a value of $4.98 billion. This strategic pivot highlights an effort by domestic manufacturers to diversify their global footprint and reduce heavy reliance on American markets, where demand for several key items has dropped by over 50%.
Impact of the India-UK CETA Trade Agreement
The implementation of the India-UK Comprehensive Economic and Trade Agreement (CETA) on July 15 is expected to provide a significant tailwind for this shift. By reducing trade barriers and lowering tariffs on a wide range of goods, the agreement aims to make Indian products more price-competitive in British markets. For investors, this trade pact is a crucial factor, as it could improve profit margins for companies in sectors where customs duties have historically been a significant cost burden. The agreement is likely to benefit firms that are already expanding their presence in the UK, potentially boosting their revenue share from international markets.
Sector-Specific Growth Trends
The diversification strategy is showing clear results across multiple industries. The food processing and agriculture sectors have seen notable spikes in demand, with instant flavored coffee exports to the UK surging by 1,533%. Other high-growth areas include decorative laminates, which rose 22%, castor oil up 18%, and frozen vegetables growing 17%.
In the manufacturing and industrial space, companies focused on higher-value products are gaining ground. Anti-cancer drug exports climbed 23%, reflecting a successful move toward specialized pharmaceutical goods. Traditional labor-intensive sectors such as textiles and home furnishings also reported resilience, with cotton T-shirt exports rising 4% and carpet exports increasing 17%. Investors monitoring these companies should track whether this momentum continues post-CETA, as the ability to maintain these growth rates will depend on the cost competitiveness of these firms compared to local UK producers and other international suppliers. While the shift offers a buffer against the US slowdown, profitability will ultimately depend on managing logistics costs, maintaining quality standards, and successfully navigating the competitive pricing landscape in the European market.